Epidemiological evidence suggests that isoflavone phytoestrogens may reduce the risk of cancer, osteoporosis, and heart disease, effects at least partially mediated by estrogen receptors ␣ and ␤ (ER␣ and ER␤). Because isoflavone dietary supplements are becoming increasingly popular and are frequently advertised as natural alternatives to estrogen replacement therapy, we have examined the effects of one of these supplements on estrogen-dependent behavior and ER␣-and ER␤-dependent gene expression in the brain. In the adult female rat brain, 17␤-estradiol treatment decreased ER␤ messenger RNA signal in the paraventricular nucleus by 41%, but supplement treatment resulted in a 27% increase. The regulation of ER␤ in the paraventricular nucleus is probably via an ER␤-dependent mechanism. Similarly, in the ventromedial nucleus of the hypothalamus, supplement treatment diminished the estrogen-dependent up-regulation of oxytocin receptor by 10.5%. The regulation of oxytocin receptor expression in the ventromedial nucleus of the hypothalamus is via an ER␣-dependent mechanism. Supplement treatment also resulted in a significant decrease in receptive behavior in estrogen-and progesterone-primed females. The observed disruption of sexual receptivity by the isoflavone supplement is probably due to antiestrogenic effects observed in the brain. These results suggest that isoflavone phytoestrogens are antiestrogenic on both ER␣-and ⌭R␤-dependent gene expression in the brain and estrogen-dependent behavior. (Endocrinology
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HYTOESTROGENS are nonsteroidal, estrogen-like compounds produced by plants. Because consumption of these compounds has been associated with a myriad of health benefits, they are becoming increasingly popular as food supplements and are frequently advertised as a natural alternative to estrogen replacement therapy (ERT). The supplement chosen for this study contains high levels of the isoflavonoid phytoestrogens genistein and daidzein. Both are found naturally in legumes and soy-based foods, including tofu, tempeh, and soy infant formula (1, 2) . They inhibit the growth of estrogen-dependent tumor cells in vitro (3, 4) , decrease the risk of heart disease through a variety of mechanisms (5) (6) (7) , and may also relieve the symptoms of menopause, including hot flashes (8) . This is the first attempt to investigate their potential actions on female sexual behavior and estrogen-dependent gene expression in the brain.
A variety of phytoestrogens have been shown to bind to both isoforms of the estrogen receptor (ER␣ and ER␤) in vitro (9, 10) and activate ER-dependent gene transcription. This evidence combined with previous observations that these compounds can increase uterine weight in vivo (11, 12) has led to the classification of phytoestrogens as weakly estrogenic. However, new evidence obtained in vivo has suggested that at least one phytoestrogen, coumestrol, may actually function as an antiestrogen in the brain (13) .
Although the potentially beneficial effects of a high phytoestrogen diet have been well documented (14 -16) , very little is known about the potential impact of these compounds on the brain and estrogen-dependent behavior. Because commercially prepared phytoestrogen supplements are becoming more widely available, and their consumption is increasing in popularity, this study seeks to examine the effects of one of them on multiple endpoints including estrogen-dependent gene transcription in the brain and the resulting impact on female sex behavior.
Lordosis is a reflexive posture made by female rodents in response to male mounting. Females will only display this posture when sexually receptive. Ovariectomized (OVX) females can be reliably induced into behavioral estrus by administering 17␤-estradiol, followed 48 h later by progesterone (for a detailed review, see Ref. 17) . The absence of female sexual behavior in ER␣ knockout mice (ER␣KO mice) demonstrates that ER␣ is critically important for the regulation of female sexual behavior (18 -20) . By contrast, ER␤KO mice show far less dramatic behavioral deficits (21) . Thus, if the supplement is antiestrogenic, particularly through ER␣, it should attenuate the lordosis response in females primed with progesterone in the absence of estrogen. Similarly, if it is estrogenic, it should enhance the lordosis response in females primed with both 17␤-estradiol and progesterone.
To distinguish through which estrogen receptor the supplement is acting, we have chosen to look at oxytocin receptor (OTR) expression in the ventromedial nucleus of the hypothalamus (VMN) because estrogen is known to signif-icantly up-regulate OTR via an ER␣-dependent mechanism (22) . If the isoflavone supplement is estrogenic via ER␣, it should up-regulate OTR in a manner similar to that of estrogen. We have also chosen ER␤ messenger RNA (mRNA) expression in the paraventricular nucleus of the hypothalamus (PVN) because estrogen down-regulates ER␤ mRNA (13) . This down-regulation of ER␤ transcription is probably an ER␤-dependent mechanism because the PVN is devoid of ER␣ (23, 24) . Again, if the isoflavone supplement is estrogenic, it should down-regulate ⌭R␤ mRNA in a manner similar to that of estrogen.
Materials and Methods Supplement
The supplement chosen for the study was purchased from a local grocery store and ground into a fine powder to ensure a homogeneous mixture using a coffee grinder. The supplement is called Super Concentrated Isoflavones with Genistein and Daidzein (Solgar Vitamin and Herb, Leonia, NJ; lot 16667; expiration date, 02/2002) and claims to have 5 mg genistein/genistin, 18 mg daidzein/daidzin, and 15 mg glycitein/ glycitin for a total of 38 mg total soy isoflavones/tablet (ϳ1.4 g). The label directs consumers to take two tablets (76 mg total isoflavones) daily. The presence of both genistein and daidzein was confirmed using HPLC analysis.
Analysis of isoflavonoid content of the supplement
The quantities of genistein and daidzein in the supplement were determined by HPLC after extraction and hydrolysis by the method of Franke et al. (1) . A sample (0.1 g) of the finely ground supplement was suspended in 5 ml 77% ethanol with 2 m HCl by sonicating for 30 min and hydrolyzed at 80 C for 2 h. Ethanol lost during hydrolysis was replaced to bring the volume to 2 ml, and the mixture was clarified by centrifuging at 2000 rpm for 10 min. Aliquots (40 and 200 l) were reconstituted to 200 l mobile phase, and 20 l were injected into the HPLC system. Chromatography was carried out using a Hypersil ODS column (5 m, 25 cm ϫ 4.6 mm; Aldrich, Milwaukee, WI). Phytoestrogens were analyzed using a reverse phase isocratic technique for the detection of isoflavonoids (25, 26) . The mobile phase was 60% methanol in 0.1 m ammonium acetate buffer, pH 4.6, with a flow rate of 1 ml/min for 16 min at 30 C. Analytes were monitored using a dual channel photodiode array detector at 255 and 280 nm. Peaks were scanned between 0 -600 nm, and the resultant absorption spectra were compared with the spectra of authentic standards to confirm the identity of peaks corresponding to the retention times of authentic standards. Retention times for isoflavonoids were as follows: daidzein, 6.1; phloretin, 7.2; equol, 6.8; genistein, 7.4; coumestrol, 9.6; and formonetin, 11.4 min. Retention times were reproducible to within a 1% coefficient of variation over a 3-month period. Detection limits obtained from authentic standards were 2-3 ng. Isoflavonoid concentrations were calculated from standard curves of the peak area responses for authentic isoflavonoid standards. Calibration curves showed high linearity (0.97-0.99) over a concentration range of 2-300 ng. Within-and between-assay coefficients of variation were less than 10%.
Animal care
Animal care, maintenance, and surgery were conducted in accordance with the applicable portions of the Animal Welfare Act and the U.S. DHHS Guide for the Care and Use of Laboratory Animals. Adult male (n ϭ 8) and female (n ϭ 73) Long Evans rats (Charles River Laboratories, Inc., Raleigh, NC) were housed in a 12-h light, 12-h dark cycle at 23 C and 50% humidity. Females were housed in groups of two; males were individually housed. Animals used for the behavioral study were kept on a reverse light cycle.
Because standard laboratory chows contain significant amounts of phytoestrogens given their high soy content (27, 28) , a semipurified, phytoestrogen-free test diet (American Institute of Nutrition formulation 76A, Purina Test Diets, Richmond, IN) was used for the preparation of the treatment diets. All animals were maintained on this diet for at least 4 days before beginning each experiment.
Behavioral testing
After a 1-week acclimation to the vivarium, all females (n ϭ 32) were OVX under ketamine anesthesia. Within a few weeks after surgery, all females were induced into estrus with estrogen (10 g in 0.1 ml sesame oil) and progesterone (500 g in 0.1 ml sesame oil) and tested with males to confirm each male's vigor and each female's sexual responsiveness to ovarian hormones. Each female was tested twice, and each male (retired breeders, Charles River Laboratories, Inc.) was tested up to six times. Males that did not reliably engage in sexual behavior after repeated exposures (reliability ϭ mating in at least 80% of pairings) were not used in the study (n ϭ 5 vigorous males). Testing began 1 week after the completion of this initial priming, and all females were fed the AIN-76A diet for 5 days before testing.
The females were divided into four treatment groups (n ϭ 8/group): isoflavone-free diet and no estrogen, isoflavone-free diet and estrogen, isoflavone diet and no estrogen, and isoflavone diet and estrogen. All animals were given progesterone. Estradiol benzoate (10 g in 0.1 ml sesame oil) was sc injected 48 h before testing, and progesterone (500 g in 0.1 ml sesame oil) was sc injected 4 -5 h before testing. Animals not receiving estrogen were injected with sesame oil (0.1 ml) only. The isoflavone diet was prepared by mixing the ground supplement into the semipurified diet as described above at a 0.35% concentration [13 parts/ million (ppm) genistein and 33 ppm daidzein]. This dose was selected because we wanted to use a physiologically, rather than pharmacologically, relevant dose. A recent study has demonstrated that this dose of genistein should produce plasma levels in Sprague Dawley rats that fall between plasma levels seen in humans eating a traditional Western diet (29) and levels in humans consuming a traditional Asian diet (16) or phytoestrogen supplements (30) . Testing took place in a double-sided arena linked by a tunnel small enough for the female, but not the male, to pass through. Each side of the arena was identical in size and shape to the home cage of each animal and was thoroughly cleaned between trials. The females were given 5 min to adapt to the arena before introduction of the male. Testing sessions were 30 min in length, and all interactions were videotaped under red light and scored from the tape. Receptivity was assessed using the lordosis quotient (LQ) as calculated by the number of lordosis responses in 10 min divided by the number of mount attempts made in the same 10 min multiplied by 100. To eliminate variability between subjects due to mount latency, the beginning of the 10-min scoring period was defined as 5 sec before the first mount attempt by the male.
Brain collection and analysis
Adult female Long Evans rats (Charles River Laboratories, Inc.; n ϭ 41) were housed in groups no larger than three on a 12-h light, 12-h dark cycle at 23 C. After a 1-week acclimation to the vivarium, all animals were OVX under ketamine anesthesia and placed on the AIN-76A diet. Ultimately, the animals were divided into four groups: no estrogen and isoflavone-free diet (n ϭ 11), estrogen and isoflavone-free diet (n ϭ 10), isoflavone diet and no estrogen (n ϭ 10), and isoflavone diet and estrogen (n ϭ 10). Estrogen was administered by SILASTIC brand capsule (Dow Corning Corp., Midland, MI), and the isoflavone diet was prepared by mixing the ground supplement into the semipurified diet as described above at a 0.35% concentration (13 ppm genistein and 33 ppm daidzein). One week after OVX, each group was placed on its designated treatment diet. Two days later, all animals were sc implanted with either an empty or a 17␤-estradiol (Sigma, St. Louis, MO)-filled SILASTIC brand capsule (9 mm in length; id, 2 mm; od, 3.2 mm) under ketamine anesthesia. Implants were chosen over injections or oral administration because implants release a steady dose of estrogen over the entire course of treatment and better simulate endogenous estrogen secretion. Similarly sized tubing has previously been shown to deliver physiological levels of 17␤-estradiol in rats (31) . Four days after implantation all animals were killed by CO 2 asphyxiation for a total of 6 days on the treatment diet and 4 days on the hormone treatment. Uteri were collected and weighed at the time of death. Blood was collected and spun down within 20 min of collection to isolate the plasma. All brains were immediately frozen on dry ice at the time of death. The plasma and brains were kept at Ϫ80 C until use. The estrogen content of each plasma sample was quantified by RIA using a modification of the Pantex Direct 125 I Estradiol kit (Pantex, Santa Monica, CA). As described previously (32, 33 ) the assay has a sensitivity of 9 pg/ml. The brains were cut on a cryostat into sections 20 m thick at 80-m intervals and thawmounted on SuperFrost Plus microscope slides (Fisher, Pittsburgh, PA). Serial sections were taken from the lateral septum to the caudal end of the VMN (corresponding to bregma Ϫ0.3 to Ϫ3.0 mm).
In situ hybridization
ER␤ in situ hybridization was performed using a set of two 48-bp, 35 S-labeled oligonucleotide probes (GTG AGG GAC ATC ATC ATG GAG GCC TCG GTG AAG GGC ATG CTG GGA CGG and GAG CTC CAC AAA GCC AGG GAT TTT CTT AGC CCA GCC AAT CAT GTG CAC). These oligonucleotides are complimentary to nucleotides 714 -762 and 784 -832 of rat ER␤ mRNA (GenBank accession no. 2801690) and are 60% and 77% homologous to ER␣, respectively. This sequence encodes the hinge region of the ER␤ receptor. The oligonucleotides were labeled using terminal transferase in a reaction containing [ 35 S]ATP (NEN Life Science Products, Boston, MA) at a concentration of 35 pmol 10 mCi/ml [ 35 S]ATP/7.5 pmol total oligonucleotides. The probe was diluted to a final concentration of 3.75 pmol of each oligonucleotide/3 ml hybridization solution (520,000 cpm/slide).
In situ hybridization was performed using a well established protocol in our laboratory as described previously (34) . After in situ hybidization, the rinsed and dried sections were exposed to Kodak BioMax MR film (Eastman Kodak Co., Rochester, NY) with 14 C-labeled autoradiographic standards (Amersham Pharmacia Biotech, Arlington Heights, IL) for 4 weeks to produce autoradiograms for quantitative analysis.
OTR autoradiography
OTR autoradiography was performed using 125 I-d(CH 2 ) 5 [Tyr(Me) 2 ,-Tyr-NH 2 9 ]OVT (NEN Life Science Products) exactly as previously described (22) . After air-drying, the slides were exposed to BioMax MR film (Kodak) for 48 h.
125 I-Labeled autoradiographic standards (Amersham Pharmacia Biotech) were included in the cassette for quantification.
Data analysis
Female sexual behavior. All behavior was scored from the videotape by a single investigator blind to the treatment groups, then validated by a second investigator. The number of mounts by the male, the number of lordotic responses by the female, and the time spent by the female in both sides of the arena were scored for each 10-min test session and averaged across each of the four treatment groups. Lordosis was defined as complete dorsoflexion of the spine in response to a mount by the male as previously described in detail (35) . A mount was defined as placement of both front limbs on the hindquarters of the female with or without intermission or ejaculation. All data, including male mounting, was analyzed by one-way ANOVA using SYSTAT (SPSS, Inc., Chicago, IL), and group differences were identified using Fisher's least significant difference post-hoc test.
Estrogen-dependent gene expression. ER␤ in situ hybridization and OTR film autoradiograms were analyzed on a Macintosh computer using the public domain NIH Image program. Brain regions from three adjacent sections per subject were measured bilaterally from anatomically matched sections, and care was taken to ensure that the area of the regions selected for measurement did not differ by more than 10% between sections and subjects. For the ER␤ autoradiograms, optical densities were converted to nanocuries per g tissue equivalents, and for the OTR autoradiograms, optical densities were converted to disintegrations per min/mg tissue equivalents using 14 C-and 35 S-labeled standards (Amersham Pharmacia Biotech). All data were analyzed by oneway ANOVA using SYSTAT, and group differences were identified using Fisher's least significant difference post-hoc test.
Results

HPLC analysis of the supplement
Isoflavone concentrations in the supplement were determined by HPLC analysis after extraction and acid hydrolysis (Fig. 1) . Daidzein and genistein were identified by comparison of retention times and absorption spectra to authentic standards. An additional peak was tentatively identified as glycitein by comparison of its spectra to published data (36) . One gram of the supplement was estimated to contain 3.7 mg genistein and 9.4 mg daidzein, levels very similar to those stated by the manufacturer (3.57 mg genistein and 12.85 mg daidzein). A standard was not available for quantification of glycitein content.
Female sexual behavior
Estrogen-treated animals showed a robust induction of lordosis behavior (LQ ϭ 91.8%) compared with the controls (LQ ϭ 6.7%; Fig. 2 ). Supplement-treated animals (LQ ϭ 7.8%) were similar to the controls, but supplement intake significantly reduced lordosis behavior in estrogen-treated animals (LQ ϭ 72.8%; P Ͻ 0.006).
There was a trend for decreased mounting by males for supplement-treated females (P Ͻ 0.06; Fig. 2 ). The time spent by the female in the arena containing the male was the same across all groups, implying that the difference seen in male mounting attempts is not complicated by differences in the amount of time that males had access to the females (data not shown). and genistein (7.54 min) along with a peak tentatively identified as glycitein (6.28 min). Absorbance scans of these peaks were identical to the spectra of authentic standards for genistein (B) and daidzein (C). A standard was not available for glycitein. For B and C, the solid line corresponds to the sample, and the dashed line corresponds to the standard.
⌭R␤ mRNA expression
Hybridization with the antisense oligonucleotide probe for ER␤ mRNA resulted in strong signals for ER␤ mRNA in the PVN but no detectable levels in the VMN (Fig. 3) . This is consistent with previous reports of ER␤ distribution in the brain (23, 24, (37) (38) (39) , which identified ER␤ to magnocellular neurons. Quantitative analysis of the signal on the film autoradiograms showed that treatment with 17␤-estradiol resulted in a 41% decrease in ER␤ mRNA expression in the PVN ( Fig. 4 ; P Ͻ 0.001) compared with that in the control group. In contrast, ingestion of a 0.35% isoflavone-supplemented diet resulted in a 27% increase (P Ͻ 0.02) compared with the control group. Treatment with both 17␤-estradiol and the isoflavone supplement resulted in a 43% decrease in ER␤ mRNA signal compared with the control group (P Ͻ 0.001) which is not significantly different from the group treated with 17␤-estradiol alone.
OTR receptor binding
Binding with the 125 I-d(CH 2 ) 5 [Tyr(Me) 2 ,Tyr-NH 2 9 ]OVT resulted in a strong signal throughout the VMN (Fig. 5) . Quantitative analysis of the signal on the film autoradiograms revealed that treatment with 17␤-estradiol resulted in a 195% increase in OTR expression in the VMN compared with the controls ( Fig. 4 ; P Ͻ 0.001), whereas treatment with the 0.35% isoflavone-supplemented diet resulted in no significant change in OTR expression compared with the controls. However, treatment with both the isoflavone diet and 17␤-estradiol resulted in a 166% increase in OTR expression in the VMN, which is significantly higher than that in the controls (P Ͻ 0.001), but significantly lower than the increase in the animals treated with 17␤-estradiol alone ( Fig. 4 ; P Ͻ 0.02).
Estrogen concentrations and uterine responses
Estradiol levels in animals given blank capsules averaged 23.5 pg/ml compared with an average of 342.3 pg/ml for those given the implants containing 17␤-estradiol. Gonadally intact rat females typically have serum 17␤-estradiol levels around 86.5 pg/ml during proestrus and 26.4 pg/ml during diestrus (40) . Thus, the estradiol levels achieved using the implants are about 4 times higher than physiological levels during proestrus, and the estradiol levels in the OVX animals given blank capsules approximate physiological levels seen during diestrus.
Treatment with the supplement did not significantly increase uterine weight (mean, 0.19 Ϯ 0.011 g) compared with the controls (mean, 0.18 Ϯ 0.009 g) or diminish the uterotropic effects of estrogen (mean, 0.62 Ϯ 0.02 g) when given in combination (mean, 0.57 Ϯ 0.026 g). This is consistent with the results of an immature rat uterotropic bioassay, which showed that a 0.35% supplemented diet did not significantly   FIG. 2 . Effects of dietary intake of a phytoestrogen supplement at a concentration of 0.35% of the total diet (ϳ13 ppm genistein and 33 ppm daidzein) on female attractivity and receptivity. A, Mount attempts are equal toward control (EϪSϪ), estrogen-treated (EϩSϪ), and estrogen-plus supplement-treated (EϩSϩ) females, but there is a trend for decreased mount attempts toward supplement-treated (EϪSϩ) females. B, Female receptivity is significantly increased in estrogen-primed females, but this effect is significantly attenuated by phytoestrogen supplementation. All females were injected with progesterone 4 -5 h before testing. Results are expressed as the mean Ϯ SEM. *, P Ͻ 0.01; **, P Ͻ 0.001; ‡, P Ͻ 0.06 (vs. EϪSϪ).
FIG. 3.
Film autoradiograms illustrating ER␤ mRNA expression in the PVN of OVX adult rat females given no 17␤-estradiol and no phytoestrogen supplement (EϪSϪ), the phytoestrogen supplement (EϪSϩ), 17␤-estradiol (EϩSϪ), and both the phytoestrogen supplement and 17␤-estradiol. Note that estrogen decreased ER␤ mRNA expression in the PVN, the phytoestrogen supplement increased ER␤ mRNA expression, and the phytoestrogen supplement could not overcome the effects of estrogen when given in combination with estrogen (supplement dose ϭ 0.35% of the total diet or ϳ13 ppm genistein and ϳ33 ppm daidzein).
increase uterine weight in juvenile females compared with the controls (data not shown).
Discussion
This is the first study to demonstrate that a readily available, commercially prepared, phytoestrogen supplement can inhibit estrogen-dependent behavior and is antiestrogenic for both ER␣-and ER␤-dependent gene expression in the brain. The behavioral data suggest that the supplement is acting as an antiestrogen. Administration of the supplement in combination with progesterone in the absence of estrogen failed to increase female receptivity. Similarly, ingestion of the isoflavone supplement in combination with both estrogen and progesterone significantly decreased female receptive behavior. This observed decrease in the lordosis quotient of hormone-primed females fed the isoflavone supplement may be the consequence of the antiestrogenic actions of the isoflavone supplement on ER␣-and ER␤-dependent gene expression in the hypothalamus.
Studies using ER␣KO mice have conclusively demonstrated that ER␣ is required for the normal expression of both male and female sexual behavior (18 -20) . Oxytocin is also known to be critical for the facilitation of sexual behavior (41, 42) , and in the PVN, ER␤ is colocalized with oxytocin (37, 38) . Thus, phytoestrogenic disruption of estrogen-dependent OTR up-regulation in the VMN coupled with antiestrogenic effects on ER␤ mRNA expression in the PVN could explain the reduced sexual receptivity of hormone-primed female rats on an isoflavone-supplemented diet.
In vitro assays have shown that phytoestrogens are capable of binding to ER␣ and activating estrogen-dependent gene transcription (43) , and that at least one phytoestrogen, resveratrol, has antagonist activity through ER␣ (10) . It has also been shown that the up-regulation of OTR by estrogen in the VMN is mediated exclusively by ER␣ (22) . The failure of the isoflavone supplement to alter OTR expression in the absence of estrogen implies that it has no estrogenic activity through ER␣ in this region at the dose used in this experiment. However, the isoflavone supplement significantly decreased the induction of OTR by estrogen in the VMN. This demonstrates that the phytoestrogens contained in the supplement interfere with the ability of estrogen to up-regulate OTR.
Similarly, in situ hybridization (24, 38) and immunocytochemical (23, 37) , studies have failed to detect ER␣ in the PVN. Therefore, it is likely that the estrogen-dependent down-regulation of ER␤ mRNA in this region is an autoregulatory effect mediated by ER␤ rather than heterologous regulation by ER␣. The up-regulation of ER␤ mRNA in the PVN by the isoflavone supplement is probably also via this mechanism and suggests that it has antiestrogenic effects on ER␤. The antiestrogenic effects on estrogen-dependent gene expression seen in the hypothalamus are consistent with at least one previous study showing that the individual phytoestrogen, coumestrol, also had the opposite effect of estrogen on ER␤ mRNA expression in the PVN (13) .
These results demonstrating that isoflavones act as antiestrogens on ER␣ and ER␤ in the brain are in contrast with results obtained in vitro showing that a variety of phytoestrogens, including genistein and daidzein, activate estrogendependent gene transcription (9, 43) . The difference between the effects found in this transfection reporter gene assay and our own in vivo findings may be due to the metabolism of the supplement after consumption or to interactions of the ligand-receptor complex with accessory binding proteins not present in the transfection assay tissue culture, but present in the PVN or VMN.
Although most studies of the estrogenic action of phytoestrogen action have been conducted using only one individual phytoestrogen, it is virtually impossible for consumers to obtain the purified compounds. Diets high in phytoestrogens, like traditional Asian diets and vegetarian diets, are high in a vast multitude of phytoestrogens, and all of the commercially prepared supplements, powders, and even soy-based infant formulas contain at least the two most common phytoestrogens, genistein and daidzein, in addition to several others (1, 2, 44) . Multiple studies have shown that human plasma, urine, and breast milk from a wide variety of cultures (45) (46) (47) (48) contain many different phytoestrogens, making it necessary and imperative to study the combined effects of these compounds.
The mental health benefits of estrogen in women are well known and often used to argue for the use of ERT in postmenopausal women. Specifically, ERT may protect against a decline in memory (49 -51) and alleviate depression (52, 53) . Because more and more women are looking to phytoestrogen-rich foods and supplements as a natural alternative to ERT, the impact of phytoestrogen supplementation on estrogen-dependent end points in the brain needs to be examined in greater detail before they can be advocated as an effective alternative to traditional ERT.
